This drug, if effective, will give us a
treatment for
diabetic neuropathy on top of regular sugar control."
Bethany Klopfenstein, M.D., a diabetologist at the OHSU Diabetes Center, serves as a co-investigator of the study. Klopfenstein, an assistant professor in the OHSU School of Medicine, said "neuropathy is one of the most disabling complications of diabetes, and also the most difficult to treat.